Effect of a reduced vitamin K supplementation on prothrombin time in prematures and high-risk neonates

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 6, 1996, Pages 747-749

  Rossi, R ^a   Albrecht, O ^a   Pollmann, H ^a   Jorch, G ^a   Harms, E ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN K GROUP;

ARTICLE; BIRTH WEIGHT; BLEEDING; CLINICAL TRIAL; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEWBORN; ORAL DRUG ADMINISTRATION; PREMATURITY; PRIORITY JOURNAL; PROTHROMBIN TIME;

EID: 0029833854     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14138.x     Document Type: Article

References (16)

1. McNinch AW, Tripp JH. Haemorrhagic disease of the newborn in the British Isles: a two year prospective study. BMJ 1991;303:1105-9
2. von Kries R, Göbel U. Vitamin K prophylaxis and vitamin K deficiency bleeding (VKDB) in early infancy. Acta Paediatr 1992;81:655-7
3. Ekelund H. Late haemorrhagic disease in Sweden 1987-1989. Acta Paediatr Scand 1991;80:966-8
4. von Kries R, Göbel U. Oral vitamin K prophylaxis and late haemorrhagic disease of the newborn [letter to the editor]. Lancet 1994;343:352
5. Golding J, Greenwood R, Birmingham K, Mott M. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992;305:341-6
6. Klebanoff MA, Read JS, Mills JL, Shiono PH. The risk of childhood cancer after neonatal exposure to vitamin K. N Engl J Med 1993;329:905-8
7. 1 increases sister chromatid exchange in vitro in human leukocytes and in vivo in fetal sheep cells: a possible role for 'vitamin K deficiency' in the fetus. Pediatr Res 1987;22:405-8
8. Cornelissen M, Smeets D, Merkx G, De Abreu R, Kollée L, Monnens L. Analyses of chromosome aberration and sister chromatid exchange in peripheral blood lymphocytes of newborns after vitamin K prophylaxis at birth. Pediatr Res 1991;30:550-3
9. Arzneimittelkommission der deutschen Ärzteschaft. Vitamin K-Prophylaxe bei Neugeborenen. Deutsches Ärzteblatt 1993;90:B53
10. Boos J, Pollmann H, Dominick C. Vitamin K-dependent coagulation parameters during the first six days of life: incidence of PIVKA II in newborns. Pediatr Hematol Oncol 1989;6:113-9
11. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104
12. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-7
13. Vermont-Oxford Trials Network Database Project. The Vermont Oxford Trials Network: very low birth weight outcomes for 1990. Pediatrics 1993;91:540-5
14. Uitentius J. Toediening van vitamine K aan pasgeborenen en zuigelingen. Ned Tijdschr Geneeskd 1990;134:1642-6
15. Arzneimittelkommission der deutschen Ärzteschaft. Vitamin K-haltige Arzneimittel zur oralen Anwendung bei Säuglingen. Deutsches Ärzteblatt 1994;91C:1981
16. Croucher C, Azzopardi D. Compliance with recommendations for giving vitamin K to newborn infants. BMJ 1994;308:894-5